Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2012/01/002349
CTRI/2012/01/002349
Recruiting
Phase 3

A comparative clinical study to evaluate the efficacy and safety of Gasex Extract route tablet in the treatment of dyspepsia. - NI

The Himalaya Drug Company0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Dyspepsia

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Dyspepsia
Sponsor
The Himalaya Drug Company
Enrollment
60
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Cases with symptoms of dyspepsia like indigestion, gaseousness, flatulence, abdominal distension \& belching.
  • •Hematologic and Biochemical parameters within normal limits.
  • •Willing to sign inform consent document

Exclusion Criteria

  • •Those with serious cardiovascular, cerebrovascular, respiratory, liver or renal disease or any other disorder.
  • •The subjects not to have used any drugs, for at least 1 week prior to the study.
  • •Subjects with a strong history of food or drug allergy of any kind.
  • •Subjects not to have been on weight reducing diets within 3 months prior to the start of the study.
  • •No other drugs (including aspirin) to be ingested during the course of the study.
  • •Patients unwilling to provide informed consent or abide by the requirements of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
A clinical study to compare the effect of Krishna Tila Kashaya and Kulatthadi Kashaya in the management of Oligomenorrhea
CTRI/2024/08/072349Rajiv Gandhi University of health sciences
Not yet recruiting
Phase 2
Ayurvedic medicine for treatment of common cold
CTRI/2019/04/018536Parul institue of ayurved
Completed
Phase 2
Role of Udumabr Ghanvati and Udumbar Ointment in white discharge.
CTRI/2017/11/010572Opd and Ipd Of Prasuti Tanta and Stree Roga200
Not yet recruiting
Phase 3
Ayurvedic Treatment in Essential Hypertension.Health Condition 1: I10- Essential (primary) hypertensionHealth Condition 2: I10- Essential (primary) hypertension
CTRI/2024/03/064342DR KIRAN KUMAR BUDIHA
Not yet recruiting
Phase 4
To study the Efficacy of Bhudhatrayadi yoga in the management of Madhumeha with special reference to type II Diabetes MellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2023/01/048727Principal